Why Are We Paying $300 for an EpiPen That Holds Only $1 Worth of Medicine?

‘In 2007, the wholesale price of the EpiPen in the US was $57. Less than a decade later, the life-saving drug now costs over $300. Each EpiPen reportedly contains only $1 worth of medicine. Mylan has a near monopoly in the US, and the company has seen its profits from the EpiPen alone skyrocket to $1 billion a year. Meanwhile, Mylan CEO Heather Bresch’s total compensation has spiked from around $2.5 million in 2007 to almost $19 million today.
In response to the price hikes, the consumer advocacy group Public Citizen and its allies will deliver a petition signed by approximately 600,000 people to Mylan’s headquarters in Canonsburg, Pennsylvania, today demanding further price cuts.’

Read more: Why Are We Paying $300 for an EpiPen That Holds Only $1 Worth of Medicine?